Xealth nets $11 million, plus more top funding news for Seattle-based companies

Xealth nets $11 million, plus more top funding news for Seattle-based companiesPhoto: Xealth/Facebook
Hoodline
Published on April 02, 2019

Seattle-based health diagnostics and digital marketing company Xealth has secured $11 million in Series A funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced March 27 and financed by Froedtert Health.

According to its Crunchbase profile, "Xealth enables healthcare teams to order digital content and services as easily as they do medications today. Patients can then access these digital health prescriptions from the provider's portal, so that they can actively manage their health. Xealth was incubated in Providence Ventures last year with an open charter to disrupt healthcare."

The four-year-old startup also raised a $8.5 million seed round in 2017.

The round brings total funding raised by Seattle companies in information technology over the past month to $51 million, and increase of $34 million from the month before. The local information technology industry has produced 54 funding rounds over the past year, capturing a total of $413 million in venture funding.

In other local funding news, real estate and company Latchel announced a $150,000 seed funding round on March 18, financed by Y Combinator.

According to Crunchbase, "Latchel provides an operations platform intended to track maintenance and vendor selection. The company's platform provides maintenance tracking and vendor selection services by property management companies to track maintenance requests, increase net margins, and increase renter satisfaction via mobile application, enabling users to connect automatically with the tenants. Latchel was founded on 2016 and is based in Seattle, Washington."

Founded in 2016, the company has raised three previous rounds, including a $420,200 pre-seed round in 2017.


This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.